Clincosm LogoSign in Get a demo

HIV-1-infection

Showing 1 - 25 of 230
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

New Treatment Strategies in Eastern European Region and in

Recruiting
  • HIV-1-infection
    • Cologne, Germany
    • +3 more
    Nov 10, 2023

    HIV-1-infection Trial (B/F/TAF)

    Not yet recruiting
    • HIV-1-infection
    • (no location specified)
    Oct 23, 2023

    HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

    Not yet recruiting
    • HIV-1-infection
    • ChAdOx1.tHIVconsv1
    • +7 more
    • San Diego, California
    • +11 more
    Oct 4, 2023

    HIV-1-infection Trial in Botswana, Malawi, South Africa (3BNC117-LS-J, 10-1074-LS-J, Placebo for 3BNC117-LS-J)

    Not yet recruiting
    • HIV-1-infection
    • Molepolole, Botswana
    • +8 more
    Sep 8, 2023

    HIV-1-infection Trial (FMT capsules, Placebo capsules)

    Not yet recruiting
    • HIV-1-infection
    • FMT capsules
    • Placebo capsules
    • (no location specified)
    Aug 31, 2023

    HIV-1-infection, Sexually Transmitted Diseases Trial in Madrid (Description)

    Completed
    • HIV-1-infection
    • Sexually Transmitted Diseases
    • Description
    • Madrid, Spain
      Hospital Universitario Infanta Leonor
    Aug 16, 2023

    Observational PIC Destination Cohort

    Not yet recruiting
    • HIV-1-infection
      • (no location specified)
      Aug 14, 2023

      HIV-1-infection, HIV Seropositivity Trial in Gent (Leucapheresis)

      Not yet recruiting
      • HIV-1-infection
      • HIV Seropositivity
      • Leucapheresis
      • Gent, Oost-Vlaanderen, Belgium
        UZ Gent
      Jul 25, 2023

      HIV-1-infection Trial (Delstrigo, KOCITAF)

      Not yet recruiting
      • HIV-1-infection
      • (no location specified)
      Jun 20, 2023

      HIV-1-infection, Metabolic Syndrome Trial (physical activity)

      Not yet recruiting
      • HIV-1-infection
      • Metabolic Syndrome
      • physical activity
      • (no location specified)
      Jun 6, 2023

      HIV-1-infection Trial in Mbeya (ART, 10E8.4/iMab, VRC07-523LS)

      Not yet recruiting
      • HIV-1-infection
      • Mbeya, Tanzania
        National Institute for Medical Research-Mbeya Medical Resarch Ce
      Jun 6, 2023

      HIV-1-infection Trial (Low-dose STP0404 (Pirmitegravir), Medium-dose STP0404 (Pirmitegravir), High-dose STP0404 (Pirmitegravir))

      Not yet recruiting
      • HIV-1-infection
      • Low-dose STP0404 (Pirmitegravir)
      • +3 more
      • (no location specified)
      May 16, 2023

      Optimising Cohorts for HIV Cure Interventions

      Recruiting
      • HIV-1-infection
      • no intervention
      • Prahran, Victoria, Australia
        Alfred Health
      May 1, 2023

      HIV-1-infection Trial in New York, Philadelphia, Nashville (INO-6160, 2 mg, Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500

      Recruiting
      • HIV-1-infection
      • INO-6160, 2 mg
      • Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500 mcg)
      • New York, New York
      • +2 more
      Apr 13, 2023

      HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

      Not yet recruiting
      • HIV-1-infection
      • VRC07-523LS
      • +7 more
      • Pathum Wan, Bangkok, Thailand
      • +1 more
      Mar 8, 2023

      HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)

      Recruiting
      • HIV-1-infection
      • Kisumu, Kenya
      • +6 more
      Feb 1, 2023

      HIV-1-infection, ART, Cd4+ Lymphocyte Deficiency Trial in Minneapolis (FT538, Vorinostat)

      Not yet recruiting
      • HIV-1-infection
      • +4 more
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      Jan 31, 2023

      HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)

      Active, not recruiting
      • HIV-1-infection
      • ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
      • Amsterdam, Noord-Holland, Netherlands
        Amsterdam University Medical Centers, location AMC
      Jan 31, 2023

      Kaposi Sarcoma, HIV-1-infection Trial (Pegylated liposomal doxorubicin, Paclitaxel)

      Not yet recruiting
      • Kaposi Sarcoma
      • HIV-1-infection
      • (no location specified)
      Jan 20, 2023

      HIV-1-infection Trial in United States (GS-5894, B/F/TAF, Standard of Care)

      Recruiting
      • HIV-1-infection
      • Los Angeles, California
      • +15 more
      Jan 13, 2023

      HIV-1-infection, Antenatal Care Trial in Lilongwe (iNSC and Adherence supporter training)

      Completed
      Has Results
      • HIV-1-infection
      • Antenatal Care
      • iNSC and Adherence supporter training
      • Lilongwe, Malawi
        Bwaila District Hospital
      Jan 9, 2023

      HIV-1-infection Trial in Aarhus (Venetoclax)

      Not yet recruiting
      • HIV-1-infection
      • Aarhus, Denmark
        Aarhus University Hospital
      Jan 5, 2023

      Abacavir and Lamivudine Anabolites

      Completed
      • HIV-1-infection
      • Blood collection
      • +3 more
      • Aurora, Colorado
        University of Colorado Hospital
      Jan 5, 2023

      HIV-1-infection Trial in Umlazi (Vesatolimod, VRC07523LS, CAP256V2LS)

      Recruiting
      • HIV-1-infection
      • Umlazi, South Africa
        FRESH Clinical Research Site: Females Rising through Education,
      Jan 4, 2023

      HIV-1-infection Trial in Saint Louis (Biktarvy Tab)

      Terminated
      • HIV-1-infection
      • Biktarvy Tab
      • Saint Louis, Missouri
        Southampton Healthcare, Inc.
      Jan 3, 2023